Research Article - (2014) Volume 2, Issue 6
2014 WHO Clinical Molecular and Pathological (WHO-CMP) Diagnostic Criteria for the Classification and Staging of Five Distinct JAK2, MPL and CALR Mutated Myeloproliferative Neoplasms
- Jan Jacques Michiels1*, Karel Forstier2, Fransje Valster3, Vincent Potters3, Katrien Schelfout3 and Hendrik De Raeve4,5
- 1International Collaboration and Research on Myeloproliferative Neoplasms: ICAR. MPN, Goodheart Insititute in Nature Medicine and Health, The Netherlands
- 2Department of Hematology, Rotterdam, The Netherlands
- 3Department of Internal Medicine, University Hospital Brussels, Belgium
- 4Department of Pathology, Lievensberg Hospital Bergen op Zoom, OLV Hospital Aalst, The Netherlands
- 5Department of Pathology, University Hospital Brussels, Belgium
*Corresponding Author:
Jan Jacques Michiels, Goodheart Institute, Bloodcoagulation and Vascular Medicine Center, Erasmus Tower, Veenmos 13, 3069 AT Rotterdam, The Netherlands, Tel: +81-22-717-7312, Fax: +81-22-717-7316
Email:
